tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Humacyte initiated with an Overweight at Barclays
PremiumThe FlyHumacyte initiated with an Overweight at Barclays
1M ago
Humacyte’s Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Humacyte’s Earnings Call: Progress Amid Challenges
2M ago
Humacyte price target lowered to $3.50 from $5 at TD Cowen
Premium
The Fly
Humacyte price target lowered to $3.50 from $5 at TD Cowen
2M ago
Humacyte reports Q2 EPS (24c), consensus (18c)
PremiumThe FlyHumacyte reports Q2 EPS (24c), consensus (18c)
2M ago
Is HUMA a Buy, Before Earnings?
Premium
Pre-Earnings
Is HUMA a Buy, Before Earnings?
2M ago
Humacyte’s Strategic Positioning and Growth Potential: Buy Rating Affirmed by Josh Jennings
Premium
Ratings
Humacyte’s Strategic Positioning and Growth Potential: Buy Rating Affirmed by Josh Jennings
2M ago
Humacyte Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsHumacyte Approves Key Proposals at Annual Meeting
4M ago
Humacyte announces presentation of results from Phase 3 AV access study of V007
Premium
The Fly
Humacyte announces presentation of results from Phase 3 AV access study of V007
4M ago
Humacyte announces results in high-risk dialysis from V007 Pivotal Phase 3
Premium
The Fly
Humacyte announces results in high-risk dialysis from V007 Pivotal Phase 3
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100